Lymph Node Metastases, Ovarian Cancer Stage IV
Conditions
Keywords
internal mammary lymph node, supraclavicular lymph node, cardiophrenic lymph node
Brief summary
To evaluate the survival impact of extensive lymphadenectomy as part of debulking surgery in stage IVB ovarian cancer with supradiaphragmatic lymph node metastasis.
Interventions
debulking surgery as primary debulking surgery or interval debulking surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer * Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm) * Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer * Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020 * Patients age 18-90
Exclusion criteria
* Borderline or benign ovarian disease * Patient didn't undergo debulking surgery * Non-epithelial ovarian cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Progression-free survival | From date of treatment until the date of first documented progression or date of death (by any cause, in the absence of disease progression) whichever came first, assessed up to 120 months | the time interval from the treatment start date to disease recurrence or progression date |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | From the date of treatment start date until death due to any cause, assessed up to 120 months | the time interval from the treatment start date to death or end of study date |
Countries
South Korea